As we slip deeper into the euphoria of what has now been a decade long bull market, the initial public offering market is slipping into a similar noxious trance of its own, welcoming to U.S. exchanges record numbers of companies that lose money. According to a new report by the Wall Street Journal, more than 80% of US listed IPOs over the first three quarters of 2018 involved companies that lost money in the trailing 12 month period leading up to their IPO.
According to data, this is the highest proportion on record dating back to 1980. Not only that, but investors who have been buying these money-losing companies have been rewarded. Stocks of companies that lose money and list in the United States this year are up an average of 36% from their IPO price. This actually beat out the return for IPO stocks that are posting positive earnings, which came in at 32%. They both beat the S&P 500, which has returned 9% over the same course of time.
And because it's this easy to conjure money out of thin air, new listings have surged. During the first three quarters of 2018, $50 billion in IPO money has been raised by more than 180 companies. This puts this year on track to be the busiest year for IPOs since 2014.
A great example is the SurveyMonkey IPO, which was up more than 40% last week, despite the fact that it hasn’t ever posted a profitable year and lost $24 million in 2017. The often discussed pot stock Tilray is another great example. After listing in the United States over the summer, shares are up more than 740% in the midst of a larger boom around marijuana stocks.
Or, take for example Solid Biosciences, which not only has never generated earnings – but has never generated revenue – and disclosed to the market that one of its clinical trials was put on hold before it’s IPO in January. This was rewarded by the company raising $144 million and its stock almost tripling.
Part of the demand for IPOs likely comes from the fact that bigger name private companies, like Uber, have decided to stay private longer than companies at their stage have traditionally done. We reported on Uber's most recent $312 million quarterly loss in May.
These non-profitable IPO levels have only been seen during the peak of the dot com bubble. Back in 2000, 81% of companies going public were unprofitable. This number has been overtaken by the 83% this year. In addition to technology companies, many biotech companies – often money losing entities while they prepare for, and execute, clinical trials – have helped push this number higher.
But this hasn’t stopped investors from comparing the current environment to the dot com bubble. In 2000, 14% of tech companies that listed were profitable. This compares to 19% so far this year. Of course, the dot com bubble watched many of its once-darling companies go bust and file for bankruptcy. During the next recession, history will probably repeat itself.
Kevin Landis, chief investment officer of technology-focused Firsthand Capital Management, told the Wall Street Journal:
“The lesson from 2000 is don’t chase what everyone else is chasing.”
Of course, not every single IPO has done exceptionally well this year. ADT fell 12% on its first day of trading and shares in the company are down more than 30% since its IPO, which priced at the low-end of its initial target range earlier this year. Snapchat is also a great example. The stock is down almost 50% from its IPO price.
For now, companies can get away with the narrative that they will eventually be profitable and that investors' patience may be rewarded for investing at these early stages. However, if the broader market slips into recession, or if the panic buying slows just a little, a stark reality check could be in the cards for those believing there’s money to be made from companies where there is actually no money being made.
"The problem with young growth companies where investors have built in really optimistic assumptions is if the company doesn’t deliver, it can get revalued in a heartbeat," University of Florida finance professor Jay Ritter told the Journal.